Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis
Phase of Trial: Phase IV
Latest Information Update: 08 May 2017
At a glance
- Drugs Ticagrelor (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms TIMERA
- 03 May 2017 Planned primary completion date changed from 1 Feb 2017 to 15 Nov 2017.
- 03 May 2017 Status changed from not yet recruiting to recruiting.
- 24 Aug 2016 New trial record